Lactoferrin down-regulates G1 cyclin-dependent kinases during growth arrest of head and neck cancer cells

Clinical Cancer Research

Volumn 10, Issue 24, 2004, Pages 8683-8686

  Xiao, Yan ^a   Monitto, Constance L ^a   Minhas, Khalid M ^a   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN E; LACTOFERRIN; PROTEIN P27;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

CELL CYCLE PROTEINS; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; G1 PHASE; HEAD AND NECK NEOPLASMS; HUMANS; LACTOFERRIN; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 11144226929     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0988     Document Type: Article

References (31)

1. van der Strate BWA, Beljaars L, Molema G, Harmsen MC, Meijer DKF. Antiviral activities of lactoferrin. Antiviral Res 2001;52:225-39.
2. Sekine K, Watanabe E, Nakamura J, et al. Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn J Cancer Res 1997;88:523-6.
3. Masuda C, Wanibuchi H, Sekine K, et al. Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis. Jpn J Cancer Res 2000;91:582-8.
4. Bezault J, Bhimani R, Wiprovnick J, Furmanski P. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 1994;54:2310-12.
5. Varadhachary A, Wolf JS, Petrak K, et al. Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy. Int J Cancer 2004;111:398-403.
6. Norrby K, Mattsby-Baltzer I, Innocenti M, Tuneberg S. Orally administered bovine lactoferrin systemically inhibits VEGF(165)-mediated angiogenesis in the rat. Int J Cancer 2001;91:236-40.
7. Campbell T, Skilton RA, Coombes RC, Shousha S, Graham MD, Luqmani YA. Isolation of a lactoferrin cDNA clone and its expression in human breast cancer. Br J Cancer 1992;65:19-26.
8. 1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem 1999;74:486-98.
9. Hibi K, Trink B, Patturajan M, et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 2000;97:5462-7.
10. Zimecki M, Artym J, Chodaczek G, Kocieba M, Kruzel ML. Protective effects of lactoferrin in Escherichia coli-induced bacteremia in mice: relationship to reduced serum TNF alpha level and increased turnover of neutrophils. Inflamm Res 2004;53:292-6.
11. Pines J. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J 1995;308:697-711.
12. 1 phase progression: cycling on cue. Cell 1994;79:551-5.
13. Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995;11:211-9.
14. Sherr CJ, Roberts JM. Inhibitors of mammalian G, cyclin-dependent kinases. Genes Dev 1995;9:1149-63.
15. 1-S transition. Cell Signal 2002;14:751-9.
16. Olashaw N, Pledger WJ. Paradigms of growth control: relationship to Cdk activation. Sci STKE 2002;2002:1-14.
17. Harbour JW, Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2000;2:65-7.
18. 1 phase of the human cell cycle. Science (Wash. DC) 1992;257:1689-94.
19. 1-S phase protein kinase. Science (Wash. DC) 1992;257:1958-61.
20. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 1992;70:993-1006.
21. 1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev 1994;8:1759-71.
22. 1 cyclin-dependent kinases. Cell 1993;75:805-16.
23. Polyak K, Lee MH, Erdjument-Bromage H, et al. Cloning of P27kip1, a cyclin-cdk inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994;78:59-66.
24. Lee MH, Reynisdottir I, Massague J. Cloning of p57kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995;9:639-49.
25. Serrano M, Hannon GJ, Beach DA. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.) 1993;366:704-7.
26. Alkarain A, Slingerland J. Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer. Breast Cancer Res 2004;6:13-21.
27. Ravitz MJ, Van S, Herr KD, Wenner CE. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts. Cancer Res 1995;55:1413-6.
28. Liu W, Asa SL, Fantus IG, Walfish PG, Ezzat S. Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways. Am J Pathol 2002;260:511-9.
29. Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 1999;96:4240-5.
30. Baumrucher CR, Gibson CA, Schanbacher FL. Bovine lactoferrin binds to insulin-like growth factor-binding protein 3. Domest Anim Endocrinol 2003;24:287-303.
31. Maier B, Gluba W, Bernier B, et al. Modulation of mammalian lifespan by the short isoform of p53. Genes Dev 2004;18:306-19.